Maruti Suzuki cars to get costlier by 1.1%

Maruti Suzuki cars to get costlier by 1.1%

The change in cost will come into effect from January 16 and the indicative figure is calculated using ex-showroom prices of models in Delhi.

FPJ Web DeskUpdated: Monday, January 16, 2023, 10:29 AM IST
article-image
Maruti Suzuki cars to get costlier by 1.1% | File/ Representative image

Maruti Suzuki on Monday announced a 1.1 per cent price hike across all models through an exchange filing. The change in cost will take effect on January 16, and the indicative figure is calculated using ex-showroom prices of models in Delhi.

The company, which makes the Baleno, Dzire, Celerio, Ignis, WagonR, and Swift cars, said that the cost will increase based on the model of the vehicle.

Other carmakers like Hyundai, Tata Motors, Audi, and Mercedes-Benz have also announced plans to increase the cost of their offerings this month to manage the impact of increasing costs. The companies had earlier stated that the costs would be increasing due to a shortage of semiconductors and other factors like inflation and recent regulatory requirements.

Car sales in India are going up after being disrupted during COVID-19, and the companies are expanding production of vehicles. Maruti Suzuki is also planning to build a new factory in Haryana.

RECENT STORIES

IRB Infrastructure Posts 16% Year-On-Year Rise In Toll Revenue To ₹716 Crore In November 2025

IRB Infrastructure Posts 16% Year-On-Year Rise In Toll Revenue To ₹716 Crore In November 2025

Rupee Slips 20 Paise To 90.07 Against US Dollar, Tariff Concerns & US FED Reserve Policy Decision...

Rupee Slips 20 Paise To 90.07 Against US Dollar, Tariff Concerns & US FED Reserve Policy Decision...

Sensex, Nifty Open In Green After Two Days Of Consecutive Losses, Amid Mixed Global Cues & Investor...

Sensex, Nifty Open In Green After Two Days Of Consecutive Losses, Amid Mixed Global Cues & Investor...

US Threat Of Imposing Additional Tariffs On Indian Rice Is 'Not A Major Concern', Demand Remains...

US Threat Of Imposing Additional Tariffs On Indian Rice Is 'Not A Major Concern', Demand Remains...

Pharma Firm Corona Remedies' IPO Receives 9.33 Times Subscription On The Second Day Of The Share...

Pharma Firm Corona Remedies' IPO Receives 9.33 Times Subscription On The Second Day Of The Share...